JAZZ PHARMACEUTICALS PLC (JAZZ)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for JAZZ
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JAZZ | Executive Vice President, Global Head of Research and Development and Chief Medical Officer | 59 | ["B.S. from The Catholic University of America","M.D. from Yale University","M.S.C.E. from University of Pennsylvania","Residency in Pediatrics at Johns Hopkins University","Fellowship in Pediatric Hematology-Oncology at Johns Hopkins University","Board member of Autolus Therapeutics plc since June 2023","Former director at Jounce Therapeutics, Inc. from January 2020 to May 2023","Former director at iTeos Therapeutics, Inc. from May 2021 to August 2025","Previously served roles at Immunomedics, Inc. and AstraZeneca plc"] | ["Cancer Steering Committee of the Foundation for the National Institutes of Health"] | 2026 |